Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae

Virology

Volumn 422, Issue 1, 2012, Pages 59-69

  Lou, Sai ^a   Xu, Baoyan ^b   Huang, Qinfeng ^c   Zhi, Ning ^b   Cheng, Fang ^c   Wong, Susan ^b   Brown, Kevin ^b   Delwart, Eric ^d   Liu, Zhengwen ^a   Qiu, Jianming ^c  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^d BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

Gene expression; Parvovirus

Indexed keywords

MESSENGER RNA; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 1A; PROTEIN VP1; PROTEIN VP2; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; EX VIVO STUDY; GENE EXPRESSION PROFILING; GENE SEQUENCE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN PARVOVIRUS 4; NUCLEOTIDE SEQUENCE; PARECHOVIRUS; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SPLICING; VIRUS CHARACTERIZATION; VIRUS GENOME; VIRUS REPLICATION;

AMINO ACID SEQUENCE; CAPSID; CAPSID PROTEINS; CELL CYCLE CHECKPOINTS; DNA, VIRAL; GENE EXPRESSION PROFILING; GENOME, VIRAL; HEK293 CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; PHYLOGENY; RNA SPLICING; VIRAL NONSTRUCTURAL PROTEINS;

HUMAN PARVOVIRUS 4; MIRIDAE; PARVOVIRIDAE; PARVOVIRUS;

EID: 82355175183     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.09.033     Document Type: Article

References (55)

1. Adlhoch C., Kaiser M., Ellerbrok H., Pauli G. High prevalence of porcine Hokovirus in German wild boar populations. Virol. J. 2010, 7:171.
2. Ahn J.K., Pitluk Z.W., Ward D.C. The GC box and TATA transcription control elements in the P38 promoter of the minute virus of mice are necessary and sufficient for transactivation by the nonstructural protein NS1. J. Virol. 1992, 66:3776-3783.
3. Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:12891-12896.
4. Anderson S., Momoeda M., Kawase M., Kajigaya S., Young N.S. Peptides derived from the unique region of B19 parvovirus minor capsid protein elicit neutralizing antibodies in rabbits. Virology 1995, 206:626-632.
5. Benjamin L.A., Lewthwaite P., Vasanthapuram R., Zhao G., Sharp C., Simmonds P., Wang D., Solomon T. Human parvovirus 4 as potential cause of encephalitis in children, India. Emerg. Infect. Dis. 2011, 17:1484-1487.
6. Brown K.E. The expanding range of parvoviruses which infect humans. Rev. Med. Virol. 2010, 20:231-244.
7. Chen A.Y., Qiu J. Parvovirus infetcion-induced cell detah and cell cycel arrest. Futur. Virol. 2010, 5:731-741.
8. Chen A.Y., Cheng F., Lou S., Luo Y., Liu Z., Delwart E., Pintel D., Qiu J. Characterization of the gene expression profile of human bocavirus. Virology 2010, 403:145-154.
9. Chen A.Y., Guan W., Lou S., Liu Z., Kleiboeker S., Qiu J. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells. J. Virol. 2010, 84:12385-12396.
10. Chen A.Y., Zhang E.Y., Guan W., Cheng F., Kleiboeker S., Yankee T.M., Qiu J. The small 11 kDa non-structural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood 2010, 115:1070-1080.
11. Chen A.Y., Kleiboeker S., Qiu J. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIF alpha. PLoS Pathog. 2011, 7:e1002088.
12. Cheng F., Chen A.Y., Best S.M., Bloom M.E., Pintel D., Qiu J. The capsid proteins of Aleutian mink disease virus (AMDV) activate caspases and are specifically cleaved during infection. J. Virol. 2009, 84:2687-2696.
13. Cotmore S.F., Tattersall P. A rolling-haipin strategy: basic mechanisms of DNA replication in the parvoviruses. Parvoviruses 2005, 171-181. London, Hoddler Arond. J. Kerr, S.F. Cotmore, M.E. Bloom, R.M. Linden, C.R. Parrish (Eds.).
14. Cotmore S.F., Tattersall P. Structure and organization of the viral genome. Parvoviruses 2005, 73-94. London, Hodder Arnold. J. Kerr, S.F. Cotmore, M.E. Bloom, R.M. Linden, C.R. Parrish (Eds.).
15. Cotmore S.F., Tattersall P. Parvoviral host range and cell entry mechanisms. Adv. Virus Res. 2007, 70:183-232.
16. Cotmore S.F., D'Abramo A.M., Ticknor C.M., Tattersall P. Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly. Virology 1999, 254:169-181.
17. Di P.G., Chiorini J.A. PKA/PrKX activity is a modulator of AAV/adenovirus interaction. EMBO J. 2003, 22:1716-1724.
18. Dorsch S., Liebisch G., Kaufmann B., von L.P., Hoffmann J.H., Drobnik W., Modrow S. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J. Virol. 2002, 76:2014-2018. 2014-2018.
19. Farr G.A., Zhang L.G., Tattersall P. Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:17148-17153.
20. Farr G.A., Cotmore S.F., Tattersall P. VP2 cleavage and the leucine ring at the base of the fivefold cylinder control pH-dependent externalization of both the VP1 N terminus and the genome of minute virus of mice. J. Virol. 2006, 80:161-171.
21. Guan W., Cheng F., Yoto Y., Kleiboeker S., Wong S., Zhi N., Pintel D.J., Qiu J. Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome. J. Virol. 2008, 82:9951-9963.
22. Jindal H.K., Yong C.B., Wilson G.M., Tam P., Astell C.R. Mutations in the NTP-binding motif of minute virus of mice (MVM) NS-1 protein uncouple ATPase and DNA helicase functions. J. Biol. Chem. 1994, 269:3283-3289.
23. Jones M.S., Kapoor A., Lukashov V.V., Simmonds P., Hecht F., Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J. Virol. 2005, 79:8230-8236.
24. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
25. Lau S.K., Woo P.C., Tse H., Fu C.T., Au W.K., Chen X.C., Tsoi H.W., Tsang T.H., Chan J.S., Tsang D.N., Li K.S., Tse C.W., Ng T.K., Tsang O.T., Zheng B.J., Tam S., Chan K.H., Zhou B., Yuen K.Y. Identification of novel porcine and bovine parvoviruses closely related to human parvovirus 4. J. Gen. Virol. 2008, 89:1840-1848.
26. Legendre D., Rommelaere J. Targeting of promoters for trans activation by a carboxy-terminal domain of the NS-1 protein of the parvovirus minute virus of mice. J. Virol. 1994, 68:7974-7985.
27. Longhi E., Bestetti G., Acquaviva V., Foschi A., Piolini R., Meroni L., Magni C., Antinori S., Parravicini C., Corbellino M. Human parvovirus 4 in the bone marrow of Italian patients with AIDS. AIDS 2007, 21:1481-1483.
28. Manning A., Russell V., Eastick K., Leadbetter G.H., Hallam N., Templeton K., Simmonds P. Epidemiological profile and clinical associations of human bocavirus and other human parvoviruses. J. Infect. Dis. 2006, 194:1283-1290.
29. Manning A., Willey S.J., Bell J.E., Simmonds P. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus. J. Infect. Dis. 2007, 195:1345-1352.
30. Mingozzi F., High K.A. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet. 2011, 12:341-355.
31. Momoeda M., Wong S., Kawase M., Young N.S., Kajigaya S. A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity. J. Virol. 1994, 68:8443-8446.
32. Naeger L.K., Schoborg R.V., Zhao Q., Tullis G.E., Pintel D.J. Nonsense mutations inhibit splicing of MVM RNA in cis when they interrupt the reading frame of either exon of the final spliced product. Genes Dev. 1992, 6:1107-1119.
33. Nuesch J.P., Corbau R., Tattersall P., Rommelaere J. Biochemical activities of minute virus of mice nonstructural protein NS1 are modulated In vitro by the phosphorylation state of the polypeptide. J. Virol. 1998, 72:8002-8012.
34. Ozawa K., Ayub J., Hao Y.S., Kurtzman G., Shimada T., Young N. Novel transcription map for the B19 (human) pathogenic parvovirus. J. Virol. 1987, 61:2395-2406.
35. Pintel D., Dadachanji D., Astell C.R., Ward D.C. The genome of minute virus of mice, an autonomous parvovirus, encodes two overlapping transcription units. Nucleic Acids Res. 1983, 11:1019-1038.
36. Qiu J., Handa A., Kirby M., Brown K.E. The interaction of heparin sulfate and adeno-associated virus 2. Virology 2000, 269:137-147.
37. Qiu J., Nayak R., Tullis G.E., Pintel D.J. Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses. J. Virol. 2002, 76:12435-12447.
38. Qiu J., Cheng F., Burger L.R., Pintel D. The transcription profile of Aleutian Mink Disease Virus (AMDV) in CRFK cells is generated by alternative processing of pre-mRNAs produced from a single promoter. J. Virol. 2006, 80:654-662.
39. Qiu J., Yoto Y., Tullis G.E., Pintel D. Parvovirus RNA processing strategies. Parvoviruses 2006, 253-274. London, UK, Hodder Arnold. J.R. Kerr, S.F. Cotmore, M.E. Bloom, M.E. Linden, C.R. Parish (Eds.).
40. Qiu J., Cheng F., Johnson F.B., Pintel D. The transcription profile of the bocavirus bovine parvovirus is unlike those of previously characterized parvoviruses. J. Virol. 2007, 81:12080-12085.
41. Qiu J., Cheng F., Pintel D. The abundant R2 mRNA generated by aleutian mink disease parvovirus is tricistronic, encoding NS2, VP1, and VP2. J. Virol. 2007, 81:6993-7000.
42. Rosenfeld S.J., Yoshimoto K., Kajigaya S., Anderson S., Young N.S., Field A., Warrener P., Bansal G., Collett M.S. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J. Clin. Invest. 1992, 89:2023-2029.
43. Schneider B., Fryer J.F., Oldenburg J., Brackmann H.H., Baylis S.A., Eis-Hubinger A.M. Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4. Haemophilia 2008, 14:978-986.
44. Schneider B., Fryer J.F., Reber U., Fischer H.P., Tolba R.H., Baylis S.A., Eis-Hubinger A.M. Persistence of novel human parvovirus PARV4 in liver tissue of adults. J. Med. Virol. 2008, 80:345-351.
45. Schoborg R.V., Pintel D.J. Accumulation of MVM gene products is differentially regulated by transcription initiation, RNA processing and protein stability. Virology 1991, 181:22-34.
46. Sharp C.P., LeBreton M., Kantola K., Nana A., Diffo J.D., Djoko C.F., Tamoufe U., Kiyang J.A., Babila T.G., Ngole E.M., Pybus O.G., Delwart E., Delaporte E., Peeters M., Soderlund-Venermo M., Hedman K., Wolfe N.D., Simmonds P. Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J. Virol. 2010, 84:10289-10296.
47. Simmons R., Sharp C., Sims S., Kloverpris H., Goulder P., Simmonds P., Bowness P., Klenerman P. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J. Infect. Dis. 2011, 203:1378-1387.
48. Sun Y., Chen A.Y., Cheng F., Guan W., Johnson F.B., Qiu J. Molecular characterization of infectious clones of the minute virus of canines reveals unique features of bocaviruses. J. Virol. 2009, 83:3956-3967.
49. Tattersall P. The evolution of parvovirus taxonomy. Parvoviruses 2006, 5-14. London, Hodder Arond. J. Kerr, S.F. Cotmore, M.E. Bloom, R.M. Linden, C.R. Parrish (Eds.).
50. Tijssen P., Agbandje-McKenna M., Almendral J.M., Bergoin M., Flegel T.W., Hedman K., Kleinschmidt J.A., Li D., Pintel D., Tattersall P. Parvoviridae. Virus Taxonomy: Classification and Nomenclature of Viruses: Ninth Report of the International Committee on Taxonomy of Viruses 2011, Elsevier, San Diego. M.Q. King, M.J. Adams, E. Carstens, E.J. Lefkowitz (Eds.).
51. Tsao J., Chapman M.S., Agbandje M., Keller W., Smith K., Wu H., Luo M., Smith T.J., Rossmann M.G., Compans R.W. The three-dimensional structure of canine parvovirus and its functional implications. Science 1991, 251:1456-1464.
52. Walker S.L., Wonderling R.S., Owens R.A. Mutational analysis of the adeno-associated virus type 2 Rep68 protein helicase motifs. J. Virol. 1997, 71:6996-7004.
53. Wan Z., Zhi N., Wong S., Keyvanfar K., Liu D., Raghavachari N., Munson P.J., Su S., Malide D., Kajigaya S., Young N.S. Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J. Clin. Invest. 2010, 120:3530-3544.
54. Young N.S., Brown K.E. Parvovirus B19. N. Engl. J. Med. 2004, 350:586-597.
55. Zadori Z., Szelei J., Lacoste M.C., Li Y., Gariepy S., Raymond P., Allaire M., Nabi I.R., Tijssen P. A viral phospholipase A2 is required for parvovirus infectivity. Dev. Cell 2001, 1:291-302.